{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:28:41Z","timestamp":1791664121696,"version":"4.3.4"},"reference-count":94,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK108894"],"award-info":[{"award-number":["R01 DK108894"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK124408"],"award-info":[{"award-number":["R01 DK124408"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 CA164970"],"award-info":[{"award-number":["R21 CA164970"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-16-0464"],"award-info":[{"award-number":["W81XWH-16-0464"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005347","name":"American Association for the Study of Liver Diseases","doi-asserted-by":"publisher","award":["Pilot Research Award"],"award-info":[{"award-number":["Pilot Research Award"]}],"id":[{"id":"10.13039\/100005347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["26\/010.101036\/2018"],"award-info":[{"award-number":["26\/010.101036\/2018"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/010.002260\/2019"],"award-info":[{"award-number":["E-26\/010.002260\/2019"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/010.002422\/2019"],"award-info":[{"award-number":["E-26\/010.002422\/2019"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/202.701\/2019"],"award-info":[{"award-number":["E-26\/202.701\/2019"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Imbalance between regulatory and effector T lymphocytes contributes to loss of immunotolerance and plays a permissive role in the initiation, perpetuation, and progression of chronic inflammatory diseases and autoimmune disorders. Regulatory\/effector cell balance is governed by the CD39 ectonucleotidase, the prototype member of the NTPDase family that hydrolyzes ATP and ADP into AMP, subsequently converted into adenosine by CD73. Generation of adenosine impacts T-cell function as it contributes to the mechanism of suppression of Tregs and confers regulatory properties to pathogenic Th17-cells. CD39 cell distribution, mechanism of regulation and impact on inflammatory and regulatory signaling pathways are also discussed here. Innovative therapeutic strategies to boost CD39 levels and activity by either administering soluble ADPases or interfering with CD39 inhibitory signals are reviewed. Restoration of CD39 levels and function has enormous translational and clinical implications and should be regarded as an additional form of treatment to be deployed in the chronic inflammatory setting. The key role of CD39 in immunoregulation in the context of Crohn's disease, one of the most frequent manifestations of inflammatory bowel disease, and autoimmune hepatitis, an autoimmune disorder of the liver, is reviewed and discussed here.<\/jats:p>","DOI":"10.3389\/fcell.2020.621760","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T09:08:54Z","timestamp":1611220134000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Ectonucleotidase Modulation of Lymphocyte Function in Gut and Liver"],"prefix":"10.3389","volume":"8","author":[{"given":"Luiz Eduardo Baggio","family":"Savio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Serena","family":"Longhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fimmu.2019.00143","article-title":"Faecalibacterium prausnitzii skews human DC to Prime IL10-producing T cells through TLR2\/6\/JNK signaling and IL-10, IL-27, CD39, and IDO-1 induction","volume":"10","author":"Alameddine","year":"2019","journal-title":"Front. Immunol."},{"key":"B2","unstructured":"Regulation of ecto-apyrase CD39 (ENTPD1) expression by phosphodiesterase III (PDE3)44194428\n            BaekA. E.\n            KanthiY.\n            SuttonN. R.\n            LiaoH.\n            PinskyD. J.\n          10.1096\/fj.13-23462523901069FASEB J.272013"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.4049\/jimmunol.1400346","article-title":"CD39 and CD161 modulate Th17 responses in Crohn's disease","volume":"193","author":"Bai","year":"2014","journal-title":"J. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"8819","DOI":"10.1038\/ncomms9819","article-title":"NADH oxidase-dependent CD39 expression by CD8(+) T cells modulates interferon gamma responses via generation of adenosine","volume":"6","author":"Bai","year":"2015","journal-title":"Nat. Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1002\/hep.23510","article-title":"Deletion of CD39 on natural killer cells attenuates hepatic ischemia\/reperfusion injury in mice","volume":"51","author":"Beldi","year":"2010","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.4049\/jimmunol.1502124","article-title":"In vivo expansion of activated Foxp3+ regulatory T cells and establishment of a type 2 immune response upon IL-33 treatment protect against experimental arthritis","volume":"197","author":"Biton","year":"2016","journal-title":"J. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","article-title":"Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression","volume":"110","author":"Borsellino","year":"2007","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1158\/0008-5472.CAN-16-2684","article-title":"CD39 expression defines cell exhaustion in tumor-infiltrating CD8(+) T cells","volume":"78","author":"Canale","year":"2018","journal-title":"Cancer Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.immuni.2011.12.019","article-title":"Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression","volume":"36","author":"Chalmin","year":"2012","journal-title":"Immunity"},{"key":"B10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3748\/wjg.14.338","article-title":"Inflammatory bowel disease: genetic and epidemiologic considerations","volume":"14","author":"Cho","year":"","journal-title":"World J. Gastroenterol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nri2340","article-title":"The genetics and immunopathogenesis of inflammatory bowel disease","volume":"8","author":"Cho","year":"","journal-title":"Nat. Rev. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"676","DOI":"10.4049\/jimmunol.1003884","article-title":"Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production","volume":"187","author":"Clayton","year":"2011","journal-title":"J. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J. Exp. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1038\/s41467-018-05072-0","article-title":"Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors","volume":"9","author":"Duhen","year":"2018","journal-title":"Nat. Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1111\/j.1600-6143.2010.03291.x","article-title":"Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype","volume":"10","author":"Dwyer","year":"2010","journal-title":"Am. J. Transplant."},{"key":"B16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s10875-009-9345-1","article-title":"Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease","volume":"30","author":"Eastaff-Leung","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1182\/blood-2008-06-165746","article-title":"Central role of Sp1-regulated CD39 in hypoxia\/ischemia protection","volume":"113","author":"Eltzschig","year":"2009","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.celrep.2016.01.002","article-title":"Expression of CD39 on activated T cells impairs their survival in older individuals","volume":"14","author":"Fang","year":"2016","journal-title":"Cell Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"7602","DOI":"10.4049\/jimmunol.0901881","article-title":"CD39+Foxp3+ regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis","volume":"183","author":"Fletcher","year":"2009","journal-title":"J. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"16788","DOI":"10.1073\/pnas.0902869106","article-title":"From the cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease","volume":"106","author":"Friedman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B21","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/ni.1915","article-title":"Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells","volume":"11","author":"Gandhi","year":"2010","journal-title":"Nat. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"8367","DOI":"10.1096\/fj.201902664","article-title":"The TGF-b\/SOX4 axis and ROS-driven autophagy co-mediate CD39 expression in regulatory T-cells","volume":"34","author":"Gerner","year":"2020","journal-title":"FASEB J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1097\/MIB.0000000000000566","article-title":"Heightened expression of CD39 by regulatory T lymphocytes is associated with therapeutic remission in inflammatory bowel disease","volume":"21","author":"Gibson","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.celrep.2016.09.082","article-title":"AHR activation is protective against colitis driven by T cells in humanized mice","volume":"17","author":"Goettel","year":"2016","journal-title":"Cell Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1002\/eji.1830221031","article-title":"The CD39 molecule defines distinct cytotoxic subsets within alloactivated human CD8-positive cells","volume":"22","author":"Gouttefangeas","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/hep.26583","article-title":"Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis","volume":"59","author":"Grant","year":"2014","journal-title":"Hepatology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1021\/bi015563h","article-title":"Transmembrane domains confer different substrate specificities and adenosine diphosphate hydrolysis mechanisms on CD39, CD39L1, and chimeras","volume":"41","author":"Grinthal","year":"2002","journal-title":"Biochemistry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s11302-005-5907-8","article-title":"CD39, NTPDase 1, is attached to the plasma membrane by two transmembrane domains. Why?","volume":"2","author":"Grinthal","year":"2006","journal-title":"Purinergic Signal"},{"key":"B29","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.celrep.2016.06.009","article-title":"Ecto-ATPase CD39 inactivates isoprenoid-derived Vgamma9Vdelta2 T cell phosphoantigens","volume":"16","author":"Gruenbacher","year":"2016","journal-title":"Cell Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1005177","DOI":"10.1371\/journal.ppat.1005177","article-title":"CD39 expression identifies terminally exhausted CD8+ T cells","volume":"11","author":"Gupta","year":"2015","journal-title":"PLoS Pathog."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1111\/ajd.12561","article-title":"Phenotypical analysis of ectoenzymes CD39\/CD73 and adenosine receptor 2A in CD4(+) CD25(high) Foxp3(+) regulatory T-cells in psoriasis","volume":"59","author":"Han","year":"2018","journal-title":"Aust. J. Dermatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1006\/bbrc.1996.0162","article-title":"Purification and cloning of a soluble ATP-diphosphohydrolase (apyrase) from potato tubers (Solanum tuberosum)","volume":"218","author":"Handa","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.4049\/jimmunol.0901851","article-title":"SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning","volume":"184","author":"Hart","year":"2010","journal-title":"J. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0140-6736(12)62163-1","article-title":"Autoimmune hepatitis","volume":"382","author":"Heneghan","year":"2013","journal-title":"Lancet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.cell.2019.10.027","article-title":"Mucosal profiling of pediatric-onset colitis and IBD reveals common pathogenics and therapeutic pathways","volume":"179","author":"Huang","year":"2019","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"33116","DOI":"10.1074\/jbc.271.51.33116","article-title":"Identification and characterization of CD39\/vascular ATP diphosphohydrolase","volume":"271","author":"Kaczmarek","year":"1996","journal-title":"J. Biol. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1161\/01.ATV.0000018305.95943.F7","article-title":"Reversal of thrombin-induced deactivation of CD39\/ATPDase in endothelial cells by HMG-CoA reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism","volume":"22","author":"Kaneider","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1006\/bbrc.1999.1254","article-title":"CD39 as a caveolar-associated ectonucleotidase","volume":"262","author":"Kittel","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"7144","DOI":"10.4049\/jimmunol.0902739","article-title":"IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10","volume":"184","author":"Kochetkova","year":"2010","journal-title":"J. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1074\/jbc.275.3.2057","article-title":"Palmitoylation targets CD39\/endothelial ATP diphosphohydrolase to caveolae","volume":"275","author":"Koziak","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11302-005-6217-x","article-title":"Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8","volume":"1","author":"Kukulski","year":"2015","journal-title":"Purinergic Signal"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s10620-010-1425-9","article-title":"Variable impact of CD39 in experimental murine colitis","volume":"56","author":"Kunzli","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1053\/j.gastro.2019.12.027","article-title":"Expression of free fatty acid receptor 2 by dendritic cells prevents their expression of interleukin 27 and is required for maintenance of mucosal barrier and immune response against colorectal tumors in mice","volume":"158","author":"Lavoie","year":"2020","journal-title":"Gastroenterology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1183\/13993003.02144-2014","article-title":"NTPDase1\/CD39 and aberrant purinergic signalling in the pathogenesis of COPD","volume":"47","author":"Lazar","year":"2016","journal-title":"Eur. Respir. J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jaut.2016.05.005","article-title":"CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease","volume":"72","author":"Liberal","year":"2016","journal-title":"J. Autoimmun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/hep.21658","article-title":"Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2","volume":"46","author":"Longhi","year":"2007","journal-title":"Hepatology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e87956","DOI":"10.1371\/journal.pone.0087956","article-title":"Characterization of human CD39+ Th17 cells with suppressor activity and modulation in inflammatory bowel disease","volume":"9","author":"Longhi","year":"2014","journal-title":"PLoS ONE"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e92791","DOI":"10.1172\/jci.insight.92791","article-title":"Bilirubin suppresses Th17 immunity in colitis by upregulating CD39","volume":"2","author":"Longhi","year":"2017","journal-title":"JCI Insight"},{"key":"B49","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","article-title":"Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2","volume":"130","author":"Ma","year":"2006","journal-title":"Gastroenterology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jid.2016.08.023","article-title":"Down-regulation of CD62L shedding in T cells by CD39(+) regulatory T cells leads to defective sensitization in contact hypersensitivity reactions","volume":"137","author":"Mahnke","year":"2017","journal-title":"J. Invest Dermatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"7176","DOI":"10.1074\/jbc.M109.047423","article-title":"Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells","volume":"285","author":"Mandapathil","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nm.3868","article-title":"Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha","volume":"21","author":"Mascanfroni","year":"2015","journal-title":"Nat. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/ni.2695","article-title":"IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39","volume":"14","author":"Mascanfroni","year":"2013","journal-title":"Nat. Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1038\/sj.onc.1205515","article-title":"Antisense to epstein barr virus-encoded LMP1 does not affect the transcription of viral and cellular proliferation-related genes, but induces phenotypic effects on EBV-transformed B lymphocytes","volume":"21","author":"Masciarelli","year":"2002","journal-title":"Oncogene"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1053\/j.gastro.2005.03.043","article-title":"Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease","volume":"128","author":"Maul","year":"2005","journal-title":"Gastroenterology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.4049\/jimmunol.0901036","article-title":"The effector T cell response to ryegrass pollen is counterregulated by simultaneous induction of regulatory T cells","volume":"184","author":"Mittag","year":"2010","journal-title":"J. Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nm0402-358","article-title":"CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness","volume":"8","author":"Mizumoto","year":"2002","journal-title":"Nat. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"12269","DOI":"10.1073\/pnas.1918196117","article-title":"Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-alpha-dependent pathways","volume":"117","author":"Morianos","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B59","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1073\/pnas.131067798","article-title":"Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin","volume":"98","author":"Moser","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/eji.201545939","article-title":"IL-12 and IL-4 activate a CD39-dependent intrinsic peripheral tolerance mechanism in CD8(+) T cells","volume":"46","author":"Noble","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1165\/rcmb.2012-0180OC","article-title":"Pulmonary natural killer T cells play an essential role in mediating hyperoxic acute lung injury","volume":"48","author":"Nowak-Machen","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.cell.2013.08.041","article-title":"Genetic variants regulating immune cell levels in health and disease","volume":"155","author":"Orru","year":"2013","journal-title":"Cell"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1038\/ncomms3909","article-title":"Adenosine is required for sustained inflammasome activation via the A(2)A receptor and the HIF-1alpha pathway","volume":"4","author":"Ouyang","year":"2013","journal-title":"Nat. Commun."},{"key":"B64","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.4049\/jimmunol.1502506","article-title":"ATP-induced inflammation drives tissue-resident Th17 cells in metabolically unhealthy obesity","volume":"196","author":"Pandolfi","year":"2016","journal-title":"J. Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"26406","DOI":"10.1074\/jbc.M413927200","article-title":"Cholesterol-dependent lipid assemblies regulate the activity of the ecto-nucleotidase CD39","volume":"280","author":"Papanikolaou","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1073\/pnas.1810254116","article-title":"IL-27 confers a protumorigenic activity of regulatory T cells via CD39","volume":"116","author":"Park","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B67","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/hep4.1084","article-title":"The ectonucleotidase ENTPD1\/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis","volume":"1","author":"Peng","year":"2017","journal-title":"Hepatol. Commun."},{"key":"B68","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jaut.2018.01.004","article-title":"TGF-beta signalling defect is linked to low CD39 expression on regulatory T cells and methotrexate resistance in rheumatoid arthritis","volume":"90","author":"Peres","year":"2018","journal-title":"J. Autoimmun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1073\/pnas.1424792112","article-title":"Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis","volume":"112","author":"Peres","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.4049\/jimmunol.1302467","article-title":"A negative feedback loop mediated by STAT3 limits human Th17 responses","volume":"193","author":"Purvis","year":"2014","journal-title":"J. Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jaut.2014.12.007","article-title":"The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation","volume":"58","author":"Rissiek","year":"2015","journal-title":"J. Autoimmun."},{"key":"B72","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/ecco-jcc\/jjz182","article-title":"Modulation of CD39 and exogenous APT102 correct immune dysfunction in experimental colitis and Crohn's disease","volume":"14","author":"Robles","year":"2020","journal-title":"J. Crohns Colitis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2015.02.046","article-title":"The genetic architecture of the human immune system: a bioresource for autoimmunity and disease pathogenesis","volume":"161","author":"Roederer","year":"2015","journal-title":"Cell"},{"key":"B74","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.0105-2896.2006.00420.x","article-title":"Interleukin-10-secreting type 1 regulatory T cells in rodents and humans","volume":"212","author":"Roncarolo","year":"2006","journal-title":"Immunol. Rev."},{"key":"B75","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11302-017-9597-9","article-title":"Loss of vascular expression of nucleoside triphosphate diphosphohydrolase-1\/CD39 in hypertension","volume":"14","author":"Roy","year":"2018","journal-title":"Purinergic Signal"},{"key":"B76","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.3390\/ijms20194715","article-title":"Rice bran phenolic compounds regulate genes associated with antioxidant and anti-inflammatory activity in human umbilical vein endothelial cells with induced owxidative stress","volume":"20","author":"Saji","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1007\/s12035-016-0168-9","article-title":"P2X7 Receptor signaling contributes to sepsis-associated brain dysfunction","volume":"54","author":"Savio","year":"","journal-title":"Mol. Neurobiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jhep.2017.05.021","article-title":"CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury","volume":"67","author":"Savio","year":"","journal-title":"J. Hepatol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"jcs237560","DOI":"10.1242\/jcs.237560","article-title":"P2X7 receptor activation increases expression of caveolin-1 and formation of macrophage lipid rafts, thereby boosting CD39 activity","volume":"133","author":"Savio","year":"2020","journal-title":"J. Cell Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","article-title":"Bystander CD8(+) T cells are abundant and phenotypically distinct in human tumour infiltrates","volume":"557","author":"Simoni","year":"2018","journal-title":"Nature"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1053\/j.gastro.2010.05.007","article-title":"CD39\/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice","volume":"139","author":"Sun","year":"2010","journal-title":"Gastroenterology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41593-019-0370-y","article-title":"Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39","volume":"22","author":"Takenaka","year":"2019","journal-title":"Nat. Neurosci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"e1055444","DOI":"10.1080\/2162402X.2015.1055444","article-title":"Human ectonucleotidase-expressing CD25(high) Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions","volume":"5","author":"Thibaudin","year":"2016","journal-title":"Oncoimmunology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10875-010-9430-5","article-title":"IL-10\/TGF-beta-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector\/memory T cells from type 1 diabetic individuals","volume":"30","author":"Torres-Aguilar","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.4049\/jimmunol.1501774","article-title":"gammadelta T cells protect the liver and lungs of mice from autoimmunity induced by scurfy lymphocytes","volume":"196","author":"Ujiie","year":"2016","journal-title":"J. Immunol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jhep.2020.06.044","article-title":"Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis","volume":"74","author":"Vuerich","year":"2020","journal-title":"J. Hepatol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"552","DOI":"10.4161\/gmic.29797","article-title":"A commensal bacterial product elicits and modulates migratory capacity of CD39(+) CD4 T regulatory subsets in the suppression of neuroinflammation","volume":"5","author":"Wang","year":"2014","journal-title":"Gut Microbes"},{"key":"B88","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1042\/BJ20051568","article-title":"RanBPM associates with CD39 and modulates ecto-nucleotidase activity","volume":"396","author":"Wu","year":"2006","journal-title":"Biochem. J."},{"key":"B89","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jaut.2018.07.022","article-title":"HIF-1alpha-induced xenobiotic transporters promote Th17 responses in Crohn's disease","volume":"94","author":"Xie","year":"2018","journal-title":"J. Autoimmun."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.91954","article-title":"Induction of antiinflammatory purinergic signaling in activated human iNKT cells","author":"Yu","year":"2018","journal-title":"JCI Insight"},{"key":"B91","doi-asserted-by":"publisher","first-page":"166687","DOI":"10.1016\/j.jmb.2020.10.021","article-title":"B cells from patients with rheumatoid arthritis show conserved CD39-mediated regulatory function and increased CD39 expression after positive response to therapy","volume":"433","author":"Zacca","year":"2020","journal-title":"J. Mol. Biol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e18909","DOI":"10.1371\/journal.pone.0018909","article-title":"Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS ONE"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1007\/s00262-020-02629-1","article-title":"IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinoma","volume":"69","author":"Zheng","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"B94","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1111\/j.1600-6143.2009.02777.x","article-title":"Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations","volume":"9","author":"Zhou","year":"2009","journal-title":"Am. J. Transplant."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2020.621760\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T09:09:03Z","timestamp":1611220143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2020.621760\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,21]]},"references-count":94,"alternative-id":["10.3389\/fcell.2020.621760"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2020.621760","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,21]]},"article-number":"621760"}}